INFLUENCE OF METRONIDAZOLE AND CLARITHROMYCIN RESISTANCE ON H. PYLORI ERADICATION AFTER TREATMENT WITH BISMUTH, METRONIDAZOLE, TETRACYCLINE, AND OMEPRAZOLE QUADRUPLE THERAPY (PYLERA) VERSUS OMEPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN TRIPLE THERAPY

(1) UNIVERSITÉ VICTOR SEGALEN, BORDEAUX Laboratoire de, Bactériologie, Bordeaux, France

(2) Università di Bologna, Bologna, Italy

(3) Hôpital Henri Mondor, Créteil, France

(4) Axcan Pharma Inc, QC, Canada

(5) Otto-von-Guericke-Universtität, Magdeburg, Germany



This item was part of the Helicopacter Pylori III session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A390

You may be interested in:

UEG Lifetime Achievement Award 2019
English, Presentation, Pancreas, Stomach & H. Pylori, Chairman's Choice, Histopathology, 2019

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2010